<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">World Allergy Organization-McMaster University Guidelines for Allergic Disease Prevention (GLAD-P): Prebiotics</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Carlos</forename><forename type="middle">A</forename><surname>Cuello-Garcia</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Clinical Epidemiology &amp; Biostatistics</orgName>
								<orgName type="institution">McMaster University</orgName>
								<address>
									<settlement>Hamilton</settlement>
									<region>ON</region>
									<country key="CA">Canada</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department">Department of Clinical Epidemiology &amp; Biostatistics</orgName>
								<orgName type="institution">McMaster University</orgName>
								<address>
									<settlement>Hamilton</settlement>
									<region>ON</region>
									<country key="CA">Canada</country>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="institution">Tecnologico de Monterrey School of Medicine</orgName>
								<address>
									<settlement>Monterrey</settlement>
									<country key="MX">Mexico</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Alessandro</forename><surname>Fiocchi</surname></persName>
							<affiliation key="aff4">
								<orgName type="institution">Pediatric Hospital Bambino Gesù</orgName>
								<address>
									<settlement>Vatican City</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Ruby</forename><surname>Pawankar</surname></persName>
							<affiliation key="aff5">
								<orgName type="department" key="dep1">Department of Pediatrics</orgName>
								<orgName type="department" key="dep2">Nippon Medical School</orgName>
								<address>
									<settlement>Tokyo</settlement>
									<country key="JP">Japan</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Juan</forename><forename type="middle">José</forename><surname>Yepes-Nuñez</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Clinical Epidemiology &amp; Biostatistics</orgName>
								<orgName type="institution">McMaster University</orgName>
								<address>
									<settlement>Hamilton</settlement>
									<region>ON</region>
									<country key="CA">Canada</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department">Department of Clinical Epidemiology &amp; Biostatistics</orgName>
								<orgName type="institution">McMaster University</orgName>
								<address>
									<settlement>Hamilton</settlement>
									<region>ON</region>
									<country key="CA">Canada</country>
								</address>
							</affiliation>
							<affiliation key="aff6">
								<orgName type="department">School of Medicine</orgName>
								<orgName type="institution">University of Antioquia</orgName>
								<address>
									<settlement>Medellín</settlement>
									<country key="CO">Colombia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Gian</forename><forename type="middle">Paolo</forename><surname>Morgano</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Clinical Epidemiology &amp; Biostatistics</orgName>
								<orgName type="institution">McMaster University</orgName>
								<address>
									<settlement>Hamilton</settlement>
									<region>ON</region>
									<country key="CA">Canada</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department">Department of Clinical Epidemiology &amp; Biostatistics</orgName>
								<orgName type="institution">McMaster University</orgName>
								<address>
									<settlement>Hamilton</settlement>
									<region>ON</region>
									<country key="CA">Canada</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Yuan</forename><surname>Zhang</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Clinical Epidemiology &amp; Biostatistics</orgName>
								<orgName type="institution">McMaster University</orgName>
								<address>
									<settlement>Hamilton</settlement>
									<region>ON</region>
									<country key="CA">Canada</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department">Department of Clinical Epidemiology &amp; Biostatistics</orgName>
								<orgName type="institution">McMaster University</orgName>
								<address>
									<settlement>Hamilton</settlement>
									<region>ON</region>
									<country key="CA">Canada</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Kangmo</forename><surname>Ahn</surname></persName>
							<affiliation key="aff7">
								<orgName type="department">Department of Pediatrics</orgName>
								<orgName type="institution" key="instit1">Samsung Medical Center</orgName>
								<orgName type="institution" key="instit2">Sungkyunkwan University School of Medicine</orgName>
								<address>
									<settlement>Seoul</settlement>
									<country key="KR">Korea</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Suleiman</forename><surname>Al-Hammadi</surname></persName>
							<affiliation key="aff8">
								<orgName type="department" key="dep1">Department of Pediatrics</orgName>
								<orgName type="department" key="dep2">College of Medicine and Health Sciences</orgName>
								<orgName type="institution">Emirates University</orgName>
								<address>
									<settlement>Al-Ain</settlement>
									<country>United Arab, United Arab Emirates</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Arnav</forename><surname>Agarwal</surname></persName>
							<affiliation key="aff9">
								<orgName type="department">Faculty of Medicine</orgName>
								<orgName type="institution">University of Toronto</orgName>
								<address>
									<settlement>Toronto</settlement>
									<region>ON</region>
									<country key="CA">Canada</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Shreyas</forename><surname>Gandhi</surname></persName>
							<affiliation key="aff9">
								<orgName type="department">Faculty of Medicine</orgName>
								<orgName type="institution">University of Toronto</orgName>
								<address>
									<settlement>Toronto</settlement>
									<region>ON</region>
									<country key="CA">Canada</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Kirsten</forename><surname>Beyer</surname></persName>
							<affiliation key="aff10">
								<orgName type="institution">Charité Klinik für Pädiatrie</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Wesley</forename><surname>Burks</surname></persName>
							<affiliation key="aff11">
								<orgName type="department">Department of Pediatrics</orgName>
								<orgName type="institution">University of North Carolina</orgName>
								<address>
									<addrLine>Chapel Hill</addrLine>
									<region>NC</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Giorgio</forename><forename type="middle">W</forename><surname>Canonica</surname></persName>
							<affiliation key="aff12">
								<orgName type="institution">University of Genoa</orgName>
							</affiliation>
							<affiliation key="aff13">
								<orgName type="institution">IRCCS AOU San Martino-IST</orgName>
								<address>
									<settlement>Genoa</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Motohiro</forename><surname>Ebisawa</surname></persName>
							<affiliation key="aff14">
								<orgName type="department" key="dep1">Department of Allergy</orgName>
								<orgName type="department" key="dep2">Clinical Research Center for Allergology and Rheumatology</orgName>
								<orgName type="institution">Sagamihara National Hospital</orgName>
								<address>
									<settlement>Kanagawa</settlement>
									<country key="JP">Japan</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Rose</forename><surname>Kamenwa</surname></persName>
							<affiliation key="aff15">
								<orgName type="department">Department of Pediatrics and Child Health</orgName>
								<orgName type="institution">Aga Khan University Hospital</orgName>
								<address>
									<settlement>Nairobi</settlement>
									<country key="KE">Kenya</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Bee</forename><forename type="middle">Wah</forename><surname>Lee</surname></persName>
							<affiliation key="aff16">
								<orgName type="department">Department of Paediatrics</orgName>
								<orgName type="institution" key="instit1">Yong Loo Lin School of Medicine</orgName>
								<orgName type="institution" key="instit2">National University of Singapore</orgName>
								<address>
									<country>Singapore, Republic of Singapore</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Haiqi</forename><surname>Li</surname></persName>
							<affiliation key="aff17">
								<orgName type="department">Department of Primary Child Care</orgName>
								<orgName type="institution" key="instit1">Children&apos;s Hospital</orgName>
								<orgName type="institution" key="instit2">Chongqing Medical University</orgName>
								<address>
									<settlement>Chongqing</settlement>
									<country key="CN">China</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Susan</forename><surname>Prescott</surname></persName>
							<affiliation key="aff18">
								<orgName type="department" key="dep1">Department of Immunology</orgName>
								<orgName type="department" key="dep2">School of Paediatrics and Child Health</orgName>
								<orgName type="institution" key="instit1">Perth Children&apos;s Hospital</orgName>
								<orgName type="institution" key="instit2">Telethon KIDS Institute</orgName>
								<orgName type="institution" key="instit3">University of Western Australia</orgName>
								<address>
									<settlement>Crawley</settlement>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">John</forename><forename type="middle">J</forename><surname>Riva</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Clinical Epidemiology &amp; Biostatistics</orgName>
								<orgName type="institution">McMaster University</orgName>
								<address>
									<settlement>Hamilton</settlement>
									<region>ON</region>
									<country key="CA">Canada</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department">Department of Clinical Epidemiology &amp; Biostatistics</orgName>
								<orgName type="institution">McMaster University</orgName>
								<address>
									<settlement>Hamilton</settlement>
									<region>ON</region>
									<country key="CA">Canada</country>
								</address>
							</affiliation>
							<affiliation key="aff19">
								<orgName type="department">Department of Family Medicine</orgName>
								<orgName type="institution">McMaster University</orgName>
								<address>
									<settlement>Hamilton</settlement>
									<region>ON</region>
									<country key="CA">Canada</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Lanny</forename><surname>Rosenwasser</surname></persName>
							<affiliation key="aff20">
								<orgName type="department">Allergy-Immunology Division</orgName>
								<orgName type="institution">Children&apos;s Mercy Hospital &amp; University of Missouri -Kansas City School of Medicine</orgName>
								<address>
									<settlement>Kansas City</settlement>
									<region>MO</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Hugh</forename><surname>Sampson</surname></persName>
							<affiliation key="aff21">
								<orgName type="department">Icahn School of Medicine at Mount Sinai</orgName>
								<orgName type="institution">Jaffe Food Allergy Institute</orgName>
								<address>
									<settlement>New York</settlement>
									<region>NY</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Michael</forename><surname>Spigler</surname></persName>
							<affiliation key="aff22">
								<orgName type="laboratory">Food Allergy Research &amp; Education (FARE)</orgName>
								<address>
									<settlement>McLean</settlement>
									<region>VA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Luigi</forename><surname>Terracciano</surname></persName>
							<affiliation key="aff23">
								<orgName type="department">Department of Child and Maternal Medicine</orgName>
								<orgName type="institution">University of Milan Medical School at the Melloni Hospital</orgName>
								<address>
									<settlement>Milan</settlement>
									<country key="IT">Italy</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Andrea</forename><surname>Vereda</surname></persName>
							<affiliation key="aff24">
								<orgName type="department">Allergology Department</orgName>
								<orgName type="institution">Hospital Infantil Universitario Niño Jesus</orgName>
								<address>
									<settlement>Madrid</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Susan</forename><surname>Waserman</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Department of Medicine</orgName>
								<orgName type="institution">McMaster University</orgName>
								<address>
									<settlement>Hamilton</settlement>
									<region>ON</region>
									<country key="CA">Canada</country>
								</address>
							</affiliation>
							<affiliation key="aff25">
								<orgName type="department">Department of Medicine</orgName>
								<orgName type="institution">McMaster University</orgName>
								<address>
									<settlement>Hamilton</settlement>
									<region>ON</region>
									<country key="CA">Canada</country>
								</address>
							</affiliation>
						</author>
						<author role="corresp">
							<persName><forename type="first">Holger</forename><forename type="middle">J</forename><surname>Schünemann</surname></persName>
							<email>holger.schunemann@mcmaster.ca</email>
							<affiliation key="aff0">
								<orgName type="department">Department of Clinical Epidemiology &amp; Biostatistics</orgName>
								<orgName type="institution">McMaster University</orgName>
								<address>
									<settlement>Hamilton</settlement>
									<region>ON</region>
									<country key="CA">Canada</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Department of Medicine</orgName>
								<orgName type="institution">McMaster University</orgName>
								<address>
									<settlement>Hamilton</settlement>
									<region>ON</region>
									<country key="CA">Canada</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department">Department of Clinical Epidemiology &amp; Biostatistics</orgName>
								<orgName type="institution">McMaster University</orgName>
								<address>
									<settlement>Hamilton</settlement>
									<region>ON</region>
									<country key="CA">Canada</country>
								</address>
							</affiliation>
							<affiliation key="aff25">
								<orgName type="department">Department of Medicine</orgName>
								<orgName type="institution">McMaster University</orgName>
								<address>
									<settlement>Hamilton</settlement>
									<region>ON</region>
									<country key="CA">Canada</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Jan</forename><forename type="middle">L</forename><surname>Brożek</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Clinical Epidemiology &amp; Biostatistics</orgName>
								<orgName type="institution">McMaster University</orgName>
								<address>
									<settlement>Hamilton</settlement>
									<region>ON</region>
									<country key="CA">Canada</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Department of Medicine</orgName>
								<orgName type="institution">McMaster University</orgName>
								<address>
									<settlement>Hamilton</settlement>
									<region>ON</region>
									<country key="CA">Canada</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department">Department of Clinical Epidemiology &amp; Biostatistics</orgName>
								<orgName type="institution">McMaster University</orgName>
								<address>
									<settlement>Hamilton</settlement>
									<region>ON</region>
									<country key="CA">Canada</country>
								</address>
							</affiliation>
							<affiliation key="aff25">
								<orgName type="department">Department of Medicine</orgName>
								<orgName type="institution">McMaster University</orgName>
								<address>
									<settlement>Hamilton</settlement>
									<region>ON</region>
									<country key="CA">Canada</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">World Allergy Organization-McMaster University Guidelines for Allergic Disease Prevention (GLAD-P): Prebiotics</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">38D55567D974C4C2EC0702BDC8A4C631</idno>
					<idno type="DOI">10.1186/s40413-016-0102-7</idno>
					<note type="submission">Received: 15 January 2016 Accepted: 5 February 2016</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:39+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Background: The prevalence of allergic diseases in infants, whose parents and siblings do not have allergy, is approximately 10 % and reaches 20-30 % in those with an allergic first-degree relative.</s><s>Intestinal microbiota may modulate immunologic and inflammatory systemic responses and, thus, influence development of sensitization and allergy.</s><s>Prebioticsnon-digestible oligosaccharides that stimulate growth of probiotic bacteriahave been reported to modulate immune responses and their supplementation has been proposed as a preventive intervention.</s><s>Objective: The World Allergy Organization (WAO) convened a guideline panel to develop evidence-based recommendations about the use of prebiotics in the prevention of allergy.</s><s>Methods: The WAO guideline panel identified the most relevant clinical questions about the use of prebiotics for the prevention of allergy.</s><s>We performed a systematic review of randomized controlled trials of prebiotics, and reviewed the evidence about patient values and preferences, and resource requirements (up to January 2015, with an update on July 29, 2015).</s><s>We followed the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach to develop recommendations.</s><s>Results: Based on GRADE evidence to decision frameworks, the WAO guideline panel suggests using prebiotic supplementation in not-exclusively breastfed infants and not using prebiotic supplementation in exclusively breastfed infants.</s><s>Both recommendations are conditional and based on very low certainty of the evidence.</s><s>We found no experimental or observational study of prebiotic supplementation in pregnant women or in breastfeeding mothers.</s><s>Thus, the WAO guideline panel chose not to provide a recommendation about prebiotic supplementation in pregnancy or during breastfeeding, at this time.</s><s>Conclusions: WAO recommendations about prebiotic supplementation for the prevention of allergy are intended to support parents, clinicians and other health care professionals in their decisions whether or not to use prebiotics for the purpose of preventing allergies in healthy, term infants.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Executive summary</head><p><s>The purpose of this document is to provide evidencebased recommendations about the use of prebiotic supplements for the primary prevention of allergies.</s></p><p><s>Allergic diseases have a prevalence of 10 % in infants without an allergic parent or sibling, and 20 -30 % in those with allergy in their relatives.</s><s>It has been suggested that intestinal microbiota may modulate immunologic and inflammatory systemic responses and, thus, influence the development of sensitization and allergy.</s><s>Prebiotics are non-digestible food components that have been advocated as preventive interventions for allergic diseases by promoting a balanced growth of the intestinal microbiota.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Methodology</head><p><s>The methods used to develop clinical recommendations in this document follow the GRADE approach <ref type="bibr" target="#b0">[1,</ref><ref type="bibr" target="#b1">2]</ref>.</s><s>The Guideline panel included clinicians and researchers in the field of allergy (allergists), pediatricians, primary care physicians, and methodologists.</s><s>Potential conflicts of interests were managed as suggested by the World Health Organization.</s></p><p><s>The guideline panel developed and graded the recommendations and assessed the quality of the supporting evidence following the GRADE approach.</s><s>The quality of evidence (also called confidence in the available estimates of health effects or certainty in the evidence) is categorized as: high, moderate, low or very low based on consideration of risk of bias, indirectness of evidence, inconsistency and imprecision of effect estimates.</s><s>Low and very low quality evidence indicates that the estimated effects of interventions are very uncertain.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Interpretation of strong and conditional recommendations</head><p><s>The strength of a recommendation is expressed as either strong ("guideline panel recommends…"), or conditional ("guideline panel suggests…") and has the following interpretation:</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Strong recommendation</head><p><s>▪ For patients: most individuals in this situation would want the recommended course of action, and only a small proportion would not.</s><s>▪ For clinicians: most individuals should receive the intervention.</s><s>Adherence to this recommendation according to the guideline could be used as a quality criterion or performance indicator.</s><s>Formal decision aids are not likely to be needed to help individuals make decisions consistent with their values and preferences.</s></p><p><s>▪ For policy makers: the recommendation can be adopted as policy in most situations.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conditional recommendation</head><p><s>▪ For patients: the majority of individuals in this situation would want the suggested course of action, but many would not.</s><s>▪ For clinicians: recognize that different choices will be appropriate for individual patients and that you must help each patient arrive at a management decision consistent with his or her values and preferences.</s><s>Decision aids may be useful in helping individuals to make decisions consistent with their values and preferences.</s><s>▪ For policy makers: policy-making will require substantial debate and involvement of various stakeholders.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>How to use these guidelines</head><p><s>The GLAD-P guidelines about the use of prebiotics provide the basis for rational, informed decisions for clinicians, parents and other decision makers.</s><s>Clinicians, parents and other caregivers, third-party payers, institutional review committees, other stakeholders, or the courts should never view these recommendations as dictates.</s><s>No recommendation can take into account all of the often-compelling unique individual circumstances but provides guidance.</s><s>However, no one charged with evaluating health care professional's actions should attempt to apply the recommendations from these guidelines by rote or in a blanket fashion.</s></p><p><s>Note: statements about the underlying values and preferences as well as qualifying remarks accompanying each recommendation as well as the evidence to decision frameworks are its integral parts and serve to facilitate more accurate interpretation; they should never be omitted when quoting or translating recommendations from these guidelines.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Recommendations</head><p><s>Question 1.</s><s>Should prebiotics be used in pregnant women?</s></p><p><s>The WAO guideline panel chose to provide no recommendation at this time owing to lack of experimental and observational studies in which prebiotic supplements would be used in pregnant women.</s></p><p><s>Question 2. Should prebiotics be used in breastfeeding mothers?</s></p><p><s>The WAO guideline panel chose to provide no recommendation at this time owing to lack of experimental and observational studies in which prebiotic supplements would be used in breastfeeding mothers.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Question 3. Should prebiotics be used in healthy infants?</head><p><s>Recommendation: The WAO guideline panel suggests prebiotic supplementation in not-exclusively breastfed infants, both at high and at low risk for developing allergy (conditional recommendation, very low certainty of evidence).</s></p><p><s>The WAO guideline panel suggests that clinicians and parents do not use prebiotic supplementation in exclusively breastfed infants (conditional recommendation, very low certainty of the evidence).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Values and preferences</head><p><s>The recommendation to use prebiotics in notexclusively breastfed infants places a relatively higher value on possible prevention of allergies and a relatively lower value on additional cost of prebiotic supplementation.</s><s>The recommendation not to use prebiotics in exclusively breastfed infants places a relatively higher value on avoiding additional cost and burden of implementation of such supplementation and a relatively lower value on uncertain effect on prevention of allergies (currently there are also no studies of health effects of prebiotics in exclusively breastfed infants and the panel found it not justified to extrapolate from the effects observed in non-exclusively breastfed infants).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Explanations and other considerations</head><p><s>These recommendations should not lead to any change in the practice or promotion of breastfeeding in infants.</s><s>Formulas supplemented with prebiotics should not be considered a substitute for breast milk.</s><s>Sole availability of such formulas should not influence the decision to breastfeed and/or the duration of breastfeeding.</s><s>These recommendations apply to otherwise healthy term infants in whom prebiotics would be used with the goal of preventing allergies.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Scope and purpose</head><p><s>The purpose of this document is to provide guidance on the use of prebiotics for the primary prevention of allergies.</s><s>The target audience of these guidelines are general practitioners, paediatricians, allergists, pulmonologists and dermatologists.</s><s>General internists, and other health care professionals and health policy makers may also benefit from these guidelines.</s><s>Policy makers interested in these guidelines include those involved in developing local, national or international plans with the goal to reduce incidence of allergy and resource direct and indirect costs related to allergic diseases <ref type="bibr" target="#b2">[3]</ref>.</s><s>This document may also serve as the basis for development and implementation of locally adapted guidelines.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Background</head><p><s>Allergic diseases are considered a worldwide burden in different populations.</s><s>It is considered that approximately 20 % of the population will have an allergic disease at some point in their lives <ref type="bibr" target="#b3">[4]</ref>.</s><s>The prevalence of allergic diseases in infants depends on the allergic status of their parents; for example, the prevalence is 20 -30 % in those with an atopic background in their first-degree relatives, while in those without an allergic parent or sibling the risk decreases to about 10 % <ref type="bibr" target="#b4">[5]</ref>.</s></p><p><s>Recent studies have provided researchers more reasons to move their attention to the intestinal microbiota as one of the main culprits for the rising incidence of allergic disorders; its influence on sensitization and its ability to modulate immunologic and inflammatory systemic responses are the main reasons for this suspicion; <ref type="bibr" target="#b5">[6]</ref> in consequence, the "hygiene" or "microflora" hypothesis has been proposed to explain these phenomena <ref type="bibr" target="#b6">[7]</ref>.</s></p><p><s>Prebiotics have been defined as "non-digestible food components that beneficially affect the host by selectively stimulating the growth and/or activity of one or a limited number of bacteria in the colon and thereby improving host health" and later redefined as"a selectively fermented ingredient that allows specific changes, both in the composition and/or activity in the gastrointestinal microbiota that confers benefits" <ref type="bibr" target="#b5">[6,</ref><ref type="bibr" target="#b7">8,</ref><ref type="bibr" target="#b8">9]</ref>.</s></p><p><s>The Guidelines for Atopic Disease Prevention (GLAD-P) is a joint effort of the World Allergy Organization (WAO) and the Department of Clinical Epidemiology &amp; Biostatistics at McMaster University to evaluate the current evidence on the preventive effect of probiotics, prebiotics, and vitamin D on allergic diseases and related clinically important outcomes.</s><s>This document provides recommendations and the rationale for use of prebiotics.</s></p><p><s>For clarity of communication we used the following definitions throughout the document:</s></p><p><s>Prebiotics: "a selectively fermented ingredient that allows specific changes, both in the composition and/or activity in the gastrointestinal microbiota, thus conferring benefit(s) upon host health."</s><s><ref type="bibr" target="#b5">[6,</ref><ref type="bibr" target="#b7">8,</ref><ref type="bibr" target="#b8">9]</ref>.</s><s>Prebiotics most commonly used as components of infant feeds are non-digestible carbohydrates; mostly fructans like inulin, oligofructose, and fructooligosaccharides (FOS); other prebiotics in use include isomaltooligosaccharides, soybean oligosaccharides, gentiooligosaccharides, galactooligosaccharides (GOS), and xylooligosaccharides.</s><s>These are substances primarily derived from plants and commonly found in foods like garlic, onion and artichoke, among others.</s><s>To consider a substance a prebiotic, this must: a) resist gastric acidity, lysis by enzymes, and absorption in the gastrointestinal tract; b) be fermented by intestinal microbiota; and c) selectively stimulate the growth and/or activity of intestinal bacteria potentially associated with health and well-being <ref type="bibr" target="#b7">[8,</ref><ref type="bibr" target="#b8">9]</ref>.</s><s>High risk for allergy in a child: biological parent or sibling with existing or history of allergic rhinitis, asthma, eczema, or food allergy <ref type="bibr" target="#b9">[10]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Panel composition and meetings</head><p><s>We followed the procedures and methodology using the GIN-McMaster Guideline Development Checklist (http://cebgrade.mcmaster.ca/guidecheck.html)</s><s><ref type="bibr" target="#b1">[2]</ref> to assemble a team of experts including allergists, paediatricians, family physicians and representatives of the general public.</s><s>The guideline panel also included methodologists who helped prepare systematic reviews and evidence summaries following the GRADE approach.</s></p><p><s>A face-to-face meeting was held in January 2015 coinciding with the WAO Symposium in Rome, Italy.</s><s>During the meeting the guideline panel discussed specific questions, the existing research evidence and made recommendations.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Disclosure of potential conflicts of interest</head><p><s>Guideline panel members disclosed all potential conflicts of interest according to the World Health Organization policies.</s><s>The chairs (AF, RP and HJS) reviewed and resolved all potential conflicts of interest of panel members (see online Additional file 1 for the list of declared conflicts of interest for all panel members).</s><s>During all deliberations, panel members with potential conflicts of interest recused themselves from final decisions about recommendations.</s></p><p><s>The WAO provided meeting facilities during its Symposium and financial support to perform systematic reviews.</s><s>The views and interests of the WAO as well as of any commercial entity that provided external funding for WAO had no influence on the final recommendations.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Formulating specific clinical questions and determining outcomes of interest</head><p><s>We used the GRADEpro Guideline Development Tool (www.gradepro.org)</s><s><ref type="bibr" target="#b10">[11]</ref> and SurveyMonkey (surveymonkey.com) to brainstorm and subsequently prioritize questions related to the use of prebiotics for the prevention of allergy.</s></p><p><s>The following questions were chosen to be addressed in this document:</s></p><p><s>1. Should prebiotics vs. no prebiotics be used in pregnant women? 2. Should prebiotics vs. no prebiotics be used in breastfeeding women?</s></p><p><s>3. Should prebiotics vs. no prebiotics be used in infants?</s></p><p><s>The guideline panel selected outcomes of interest for each question following the general approach suggested by the GRADE Working Group <ref type="bibr" target="#b0">[1]</ref>.</s><s>All outcomes were identified a priori and the panel explicitly rated their relative importance for decision-making using an online software.</s><s>Rating outcomes by their relative importance can help focus attention on those outcomes that are considered most important and help to resolve or clarify potential disagreements.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Evidence review and development of clinical recommendations</head><p><s>Evidence summaries for each question were prepared by the methodologists (JB, CCG, JJYN, GPM, YZ, and HJS) following the GRADE approach and using the Guideline Development Tool (www.gradepro.org).</s><s>All guideline panel members reviewed the summaries of evidence and made corrections when appropriate.</s><s>We based the evidence summaries on a systematic review of the literature performed specifically for these guidelines (Reference. in preparation).</s><s>An updated search strategy (presented in the online Additional file 2) was performed on July 29, 2015 that did not provide any additional studies.</s><s>We followed the methods outlined in the Cochrane Handbook for Systematic Reviews of Interventions (handbook.cochrane.org)</s><s>and assessed the risk of bias at the outcome level using the Cochrane Collaboration's risk of bias tool <ref type="bibr" target="#b11">[12]</ref>.</s><s>Subsequently, we assessed the quality of the body of evidence (also known as certainty of evidence or confidence in the estimated effects) for each of the outcomes of interest following the GRADE approach based on the following criteria: risk of bias, precision, consistency and magnitude of the estimates of effects, directness of the evidence, risk of publications bias, presence of dose-effect relationship, and an assessment of the effect of residual, opposing confounding.</s><s>Quality (also called certainty) was categorized into 4 levels ranging from very low to high.</s><s>In addition, we searched for evidence about values and preferences and cost of prebiotic supplementation.</s><s>We prepared the evidence-todecision tables based on the estimates of the health effects, values and preferences and resource use.</s></p><p><s>During the meeting the guideline panel developed recommendations based on the evidence summaries and the evidence-to-decision frameworks <ref type="bibr" target="#b12">[13]</ref><ref type="bibr" target="#b13">[14]</ref><ref type="bibr" target="#b14">[15]</ref>.</s><s>For each recommendation, the guideline panel considered and agreed on the following: the quality of the evidence, the health balance of benefits and harms of the compared management options and the assumptions about the values and preferences associated with the decision.</s><s>The guideline panel also explicitly took into account the possible extent of resource use associated with alternative management options, feasibility, acceptability and equity considerations.</s><s>Recommendations and their strength were decided by consensus and no recommendation required voting based on the balance of all desirable and undesirable consequences.</s><s>The panel agreed on the final wording of recommendations and remarks with further qualifications for each recommendation.</s><s>The final document including recommendations was reviewed and approved by all members of the guideline panel.</s></p><p><s>We labelled the recommendations as either "strong" or "conditional" according to the GRADE approach.</s><s>We used the words "the panel members recommend" for strong recommendations and "suggest" for conditional recommendations.</s><s>Table <ref type="table">1</ref> provides the suggested interpretation of strong and conditional recommendations by patients, clinicians and health care policy makers.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Document review</head><p><s>A final draft document was reviewed by each member of the guideline panel, finalized, approved, and submitted to the WAO for peer review.</s><s>The document was revised to incorporate the pertinent comments suggested by the external reviewers.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>How to use these guidelines</head><p><s>The WAO GLAD-P guidelines about the use of prebiotics in the prevention of allergy in children are not intended to impose a standard of care.</s><s>They provide the basis for rational decisions.</s><s>Clinicians, patients, third-party payers, institutional review committees, other stakeholders, or the courts should never view these recommendations as dictates.</s><s>No recommendation can take into account all of the often-compelling unique individual circumstances.</s><s>Therefore, no one charged with evaluating health care professionals' actions should attempt to apply the recommendations from these guidelines by rote or in a blanket fashion.</s></p><p><s>Statements about the underlying values and preferences, qualifying remarks and the evidence to decision frameworks accompanying each recommendation are its integral parts and serve to facilitate more accurate interpretation.</s><s>They should never be omitted when quoting or translating recommendations from these guidelines.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Recommendations</head><p><s>Question 1.</s><s>Should prebiotics versus no prebiotics be used in pregnant women?</s><s>Summary of the evidence We found no systematic reviews, individual randomised trials or observational studies that addressed this question.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conclusions and research needs</head><p><s>The guideline panel decided that under the current circumstances, they were not able to make an informed judgment about the balance of potential desirable and undesirable consequences of using prebiotic supplements in pregnant women.</s><s>The panel determined that there is a need for well designed and executed randomized trial of prebiotic supplementation in pregnant women that would measure development of allergy in their children as well as other outcomes important in this context.</s><s>The panel identified the following additional research questions: 1) is the effect of natural prebiotics in food different from that of supplements, 2) is there an added benefit from prebiotic supplementation on top of natural prebiotics, and 3) is there a differential effect between the different types of prebiotics.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>What others are saying</head><p><s>We found no other guidelines or position statements that made specific recommendations about the use of prebiotics in pregnant women.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Recommendation 1</head><p><s>The WAO guideline panel chose to provide no recommendation at this time owing to lack of experimental and observational studies in which prebiotic supplements would be used in pregnant women.</s><s>The majority of individuals in this situation would want the suggested course of action, but many would not.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Table 1 Interpretation of strong and conditional recommendations</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Clinicians</head><p><s>Most individuals should receive the intervention.</s><s>Adherence to this recommendation according to the guideline could be used as a quality criterion or performance indicator.</s><s>Formal decision aids are not likely to be needed to help individuals make decisions consistent with their values and preferences.</s></p><p><s>Recognize that different choices will be appropriate for individual patients and that you must help each patient arrive at a management decision consistent with his or her values and preferences.</s><s>Decision aids may be useful in helping individuals to make decisions consistent with their values and preferences.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Policy makers</head><p><s>The recommendation can be adopted as policy in most situations.</s><s>Policymaking will require substantial debate and involvement of various stakeholders.</s></p><p><s>Question 2. Should prebiotics versus no prebiotics be used in breastfeeding mothers?</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Summary of the evidence</head><p><s>We found no systematic reviews or individual randomised trials or observational studies that addressed this question.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conclusions and research needs</head><p><s>Similarly to Question 1, the guideline panel decided that under current circumstances they were not able to make an informed judgment about the balance of potential desirable and undesirable consequences of using prebiotic supplements in breastfeeding mothers.</s><s>The panel determined that there is a need for randomized trials of prebiotics in breastfeeding mothers.</s><s>The additional questions provided in the discussion of Question 1 related to the effects of natural prebiotics vs. their supplements are equally relevant in the context of Question 2.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>What others are saying</head><p><s>We found no other guidelines or position statements that would make specific recommendations about the use of prebiotics in breastfeeding mothers.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Recommendation 2</head><p><s>The WAO guideline panel chose to provide no recommendation at this time owing to lack of experimental and observational studies in which prebiotic supplements would be used in breastfeeding mothers.</s></p><p><s>Question 3. Should prebiotics versus no prebiotics be used in healthy infants?</s><s>Summary of the evidence</s></p><p><s>We found three systematic reviews <ref type="bibr" target="#b15">[16]</ref><ref type="bibr" target="#b16">[17]</ref><ref type="bibr" target="#b17">[18]</ref> that addressed this question but only the review by Osborn <ref type="bibr" target="#b17">[18]</ref> assessed the use of prebiotics specifically for the prevention of allergy in infants.</s><s>We identified 15 additional studies <ref type="bibr" target="#b18">[19]</ref><ref type="bibr" target="#b19">[20]</ref><ref type="bibr" target="#b20">[21]</ref><ref type="bibr" target="#b21">[22]</ref><ref type="bibr" target="#b22">[23]</ref><ref type="bibr" target="#b23">[24]</ref><ref type="bibr" target="#b24">[25]</ref><ref type="bibr" target="#b25">[26]</ref><ref type="bibr" target="#b26">[27]</ref><ref type="bibr" target="#b27">[28]</ref><ref type="bibr" target="#b28">[29]</ref><ref type="bibr" target="#b29">[30]</ref><ref type="bibr" target="#b30">[31]</ref><ref type="bibr" target="#b31">[32]</ref><ref type="bibr" target="#b32">[33]</ref> published after the search for the Osborn review was completed and studies that measured other outcomes relevant in this context (e.g., adverse effects of prebiotic supplementation).</s><s>Altogether, there were 18 randomized trials <ref type="bibr" target="#b18">[19]</ref><ref type="bibr" target="#b19">[20]</ref><ref type="bibr" target="#b20">[21]</ref><ref type="bibr" target="#b21">[22]</ref><ref type="bibr" target="#b22">[23]</ref><ref type="bibr" target="#b23">[24]</ref><ref type="bibr" target="#b24">[25]</ref><ref type="bibr" target="#b25">[26]</ref><ref type="bibr" target="#b26">[27]</ref><ref type="bibr" target="#b27">[28]</ref><ref type="bibr" target="#b28">[29]</ref><ref type="bibr" target="#b29">[30]</ref><ref type="bibr" target="#b30">[31]</ref><ref type="bibr" target="#b31">[32]</ref><ref type="bibr" target="#b32">[33]</ref><ref type="bibr" target="#b33">[34]</ref><ref type="bibr" target="#b34">[35]</ref><ref type="bibr" target="#b35">[36]</ref> that addressed this question.</s><s>All studies included infants (from term newborns to 3 years of age) not being breastfed.</s><s>Prebiotics were either added to a cereal (two studies) <ref type="bibr" target="#b23">[24,</ref><ref type="bibr" target="#b27">28]</ref>, used as an oral capsule (one study), <ref type="bibr" target="#b28">[29]</ref> or in milk formula (15 studies) <ref type="bibr">[19-23, 25-27, 30-36]</ref>.</s><s>Online Additional file 3 presents the characteristics of all included studies.</s><s>Five studies reported the effect of prebiotic supplementation on development of eczema (either specifically atopic eczema with positive skin tests, or any eczema), <ref type="bibr" target="#b18">[19,</ref><ref type="bibr" target="#b24">25,</ref><ref type="bibr" target="#b25">26,</ref><ref type="bibr" target="#b33">34,</ref><ref type="bibr" target="#b34">35]</ref> two studies reported development of asthma or recurrent wheezing, <ref type="bibr" target="#b18">[19,</ref><ref type="bibr" target="#b24">25]</ref> one study <ref type="bibr" target="#b24">[25]</ref> assessed the risk of developing food allergy, and twelve studies <ref type="bibr">[20-24, 27, 29-31, 33, 34, 36]</ref> measured nutritional status.</s><s>No studies reported the risk of developing allergic rhinitis or the composite outcome of "any allergy".</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Benefits</head><p><s>Prebiotic supplemented during the first year of life reduced the risk of developing asthma or recurrent wheezing (RR: 0.37, 95 % CI: 0.17 to 0.80) and the risk of developing food allergy (RR: 0.28, 95 % CI: 0.08 to 1.00).</s><s>Prebiotics also probably reduce the risk for developing eczema in infants but the estimate is imprecise and confidence interval does not exclude no effect (RR: 0.57, 95 % CI: 0.30 to 1.08).</s><s>Studies assessing nutritional status assessed as weight gain found no difference between those receiving prebiotics and control groups (standardized mean difference [SMD]: 0.06, 95 % CI: -0.02 to 0.15).</s><s>Overall the certainty of these estimated effects is very low owing to the serious risk of bias in the studies and imprecision of the estimates (see evidence profile in the online Additional file 4).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Harms and burden</head><p><s>Seven studies reported adverse effects <ref type="bibr" target="#b19">[20,</ref><ref type="bibr" target="#b21">22,</ref><ref type="bibr" target="#b22">23,</ref><ref type="bibr" target="#b27">28,</ref><ref type="bibr" target="#b29">30,</ref><ref type="bibr" target="#b31">32,</ref><ref type="bibr" target="#b33">34]</ref> with a median risk of 34 % in the control groups.</s><s>All adverse effects were judged to be minor.</s><s>The risk of adverse effects was not different among those receiving prebiotics and those receiving placebo (RR: 1.03, 95 % CI: 0.93 to 1.14).</s><s>The most commonly reported adverse events were: rash, gastro-esophageal reflux, emesis, diarrhea, cramps, crying or "colic".</s><s>These events did not lead to withdrawal from the studies.</s><s>There is low certainty in the estimate of the risk of adverse effects due to inadequate reporting in primary studies.</s><s>However, given the available evidence, the guideline panel considered the risk of adverse effects most likely to be low.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Other decision criteria and considerations</head><p><s>Formulas supplemented with prebiotics should not be considered a substitute for breast milk.</s><s>All current evidence concerns infants who were not breastfed, thus, the availability of such formulas should not influence the decision to breastfeed and/or the duration of breastfeeding.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conclusions and research needs</head><p><s>The guideline panel determined that there is a low certainty of a net benefit from using prebiotics in infants.</s><s>Based on the body of available evidence, it is likely that prebiotic supplementation in infants reduces the risk of developing recurrent wheezing and possibly also the development of food allergy.</s><s>There is very low certainty that there is an effect of prebiotics on other outcomes.</s><s>However, because of low certainty of evidence or no published information about other outcomes, the fact that we did not find the evidence of an effect on these outcomes does not imply that such an effect does not exist.</s></p><p><s>The panel identified the following additional research questions: 1) is the effect of natural prebiotics in food different from that of supplementation, 2) is there an added benefit from prebiotic supplementation in addition to natural prebiotics, and 3) is there a differential effect between the different types of prebiotics.</s><s>Future research from rigorously designed and wellexecuted randomized trials may have an important impact on this recommendation.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>What others are saying</head><p><s>The European Academy of Allergy and Clinical Immunology (EAACI) Food Allergy and Anaphylaxis Guidelines state that "there is no evidence to recommend prebiotics or probiotics or other dietary supplements based on particular nutrients to prevent food allergy."</s><s><ref type="bibr" target="#b36">[37]</ref>.</s><s>The European Society for Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN) and North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) Committee on Nutrition consider that although some benefits might be conferred to the administration of prebiotics in infant formulas, these results should not influence practice until confirmed by additional studies.</s><s>They do not recommend routine administration of prebiotics for the prevention of allergies <ref type="bibr" target="#b37">[38]</ref>.</s><s>A guideline from the Scottish Intercollegiate Guidelines Network (SIGN) for the management of atopic eczema states that it is not possible to make recommendations for prebiotics to prevent allergy based on the current evidence <ref type="bibr" target="#b38">[39]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Recommendation 3</head><p><s>The WAO guideline panel suggests prebiotic supplementation in not-exclusively breastfed infants, both at high and at low risk for developing allergy (conditional recommendation, low certainty of evidence).</s></p><p><s>The WAO guideline panel suggests that clinicians and parents do not use prebiotic supplementation in exclusively breastfed infants (conditional recommendation, low certainty of the evidence).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Values and preferences</head><p><s>The recommendation to use prebiotics in notexclusively breastfed infants places a relatively higher value on possible prevention of allergies and a relatively lower value on additional cost of prebiotic supplementation.</s><s>The recommendation to not use prebiotics in exclusively breastfed infants places a relatively higher value on avoiding additional cost and burden of implementation of such supplementation and a relatively lower value on uncertain effect on prevention of allergies (currently there are also no studies of health effects of prebiotics in exclusively breastfed infants and the panel found it not justified to extrapolate from the effects observed in non-exclusively breastfed infants).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Explanations and other considerations</head><p><s>These recommendations should not lead to any change in the practice or promotion of breastfeeding of infants.</s><s>Formulas supplemented with prebiotics should not be considered a substitute for breast milk.</s><s>Sole availability of such formulas should not influence the decision to breastfeed and/or the duration of breastfeeding.</s><s>These recommendations apply to otherwise healthy infants in whom prebiotics would be used with the goal of preventing allergies.</s><s>See the evidence to recommendation table in online Additional file 5.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Priorities for revision of the guidelines</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Plans for updating these guidelines</head><p><s>Guidelines are living documents.</s><s>To remain useful, they need to be updated regularly as new information accumulates.</s><s>A revision of this document will be needed, because there was limited evidence for many clinical questions.</s><s>This document will be updated when major new research is published.</s><s>The need for update will be determined not later than in 2019.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Updating or adapting recommendations locally</head><p><s>The methods used to develop these guidelines are transparent.</s><s>The recommendations have been developed to be as specific and detailed as possible without losing sight of the simplicity of the document.</s><s>Since GLAD-P are meant as international guidelines, the guideline panel encourages feedback on all its aspects including their applicability in individual countries.</s><s>This feedback will be considered when revising the document.</s></p><p><s>Adaptation of these guidelines will be necessary in many circumstances.</s><s>Depending on when such a process takes place, the following steps should be taken: ▪ Appointing a guideline committee comprising clinicians and methodologists ▪ Determining the scope of the local guidelines ▪ Defining the relevant clinical questions to be addressed in local guidelines ▪ Reviewing and updating the evidence profiles and evidence-to-decision frameworks if necessary ▪ Reviewing the recommendations in the GLAD-P guidelines (the recommendations may need to be modified at a local level, depending on the local values and preferences, availability of medications, costs, etc.) ▪ Disseminating the guidelines, with a clear "use by" date ▪ Developing a method to obtain feedback and plans for review and update.</s><s>acquisition, analyses, and interpretation; provided significant feedback for the draft of the guideline.</s><s>KB was involved in the analysis and interpretation of the evidence, drafting of the recommendations, and provided significant feedback for the final manuscript.</s><s>WB was involved in the analysis and interpretation of the evidence, drafting of the recommendations, and provided significant feedback for the final manuscript.</s><s>GWC was involved in the analysis and interpretation of the evidence, drafting of the recommendations, and provided significant feedback for the final manuscript.</s><s>ME was involved in the analysis and interpretation of the evidence, drafting of the recommendations, and provided significant feedback for the final manuscript.</s><s>RK was involved in the analysis and interpretation of the evidence, drafting of the recommendations, and provided significant feedback for the final manuscript.</s><s>BWL was involved in the analysis and interpretation of the evidence, drafting of the recommendations, and provided significant feedback for the final manuscript.</s><s>HL was involved in the analysis and interpretation of the evidence, drafting of the recommendations, and provided significant feedback for the final manuscript.</s><s>SP was involved in the analysis and interpretation of the evidence, drafting of the recommendations, and provided significant feedback for the final manuscript.</s><s>JJR was involved in the analysis and interpretation of the evidence, drafting of the recommendations, and provided significant feedback for the final manuscript.</s><s>LR was involved in the analysis and interpretation of the evidence, drafting of the recommendations, and provided significant feedback for the final manuscript.</s><s>HS was involved in the analysis and interpretation of the evidence, drafting of the recommendations, and provided significant feedback for the final manuscript.</s><s>MS was involved in the analysis and interpretation of the evidence, drafting of the recommendations, and provided significant feedback for the final manuscript.</s><s>LT was involved in the analysis and interpretation of the evidence, drafting of the recommendations, and provided significant feedback for the final manuscript.</s><s>AV was involved in the analysis and interpretation of the evidence, drafting of the recommendations, and provided significant feedback for the final manuscript.</s><s>SW was involved in the analysis and interpretation of the evidence, drafting of the recommendations, and provided significant feedback for the final manuscript.</s><s>HJS as Chair of the Guideline Panel and principal investigator chaired and organized guideline panel meetings, ensured conflicts of interest were managed, obtained consensus on strength, direction and wording of the final recommendations, developed the initial concept and methodological design of the guideline, conducted data interpretation, and provided substantial feedback on the drafted manuscript.</s><s>JLB directed and organized guideline panel meetings and the methodologist team; was involved in the initial concept and methodological design of the guideline, conducted data acquisition and interpretation, and helped writing the final manuscript.</s><s>All authors read and approved the final manuscript.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head></head><label></label><figDesc><div><p><s>this situation would want the recommended course of action, and only a small proportion would not.</s></p></div></figDesc></figure>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgments</head><p><s>We acknowledge Gabriel Bouygue, MSc for conceiving the acronym for the guideline (GLAD-P).</s><s>Support for the dissemination of this document was provided by the founding sponsors, Danone, and Dicofarm, and by these sponsors, Bambino Gesù Ospedale Pediatrico and Heinz.</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Priorities for research</head><p><s>During the guideline development process we identified a need for more data on specific topics.</s><s>This resulted in the following recommendations for research.</s><s>We summarize these gaps in the evidence as research recommendations, to assist those in a position to provide such information through the design and execution of specific research projects.</s></p><p><s>Specific research needs to be addressed:</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Authors' contributions</head><p><s>CACG was involved in the initial concept and methodological design of the guideline.</s><s>Conducted the acquisition of data, analyses, and interpretation; drafted the article and modified according to substantial feedback from the guideline panel members (authors).</s><s>AF as Chair of the Guideline Panel, directed and organized guideline panel meetings, was involved in the initial concept and methodological design of the guideline, conducted data interpretation, and provided substantial feedback on the drafted manuscript.</s><s>RP as Chair of the Guideline Panel, directed and organized guideline panel meetings, was involved in the initial concept and methodological design of the guideline, conducted data interpretation, and provided substantial feedback on the drafted manuscript.</s><s>JJYN was involved in the methodological design of the guideline, conducted the acquisition of data, analyses, and interpretation; contributed in drafting the article and modified according to substantial feedback from the guideline panel members (authors).</s><s>GPM conducted data acquisition, analyses, and interpretation; provided significant feedback for the draft of the guideline.</s><s>YZ conducted data acquisition, analyses, and interpretation; provided significant feedback for the draft of the guideline.</s><s>KA was involved in the analysis and interpretation of the evidence, drafting of the recommendations, and provided significant feedback for the final manuscript.</s><s>SAH was involved in the analysis and interpretation of the evidence, drafting of the recommendations, and provided significant feedback for the final manuscript.</s><s>AA conducted data acquisition, analyses, and interpretation; provided significant feedback for the draft of the guideline.</s><s>SG conducted data</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">GRADE guidelines: 2. Framing the question and deciding on important outcomes</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">H</forename><surname>Guyatt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>Oxman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Kunz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Atkins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Brozek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Vist</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Epidemiol</title>
		<imprint>
			<biblScope unit="volume">64</biblScope>
			<biblScope unit="page" from="395" to="400" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Guidelines 2.0: systematic development of a comprehensive checklist for a successful guideline enterprise</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">J</forename><surname>Schunemann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Wiercioch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Etxeandia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Falavigna</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Santesso</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Mustafa</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">CMAJ</title>
		<imprint>
			<biblScope unit="volume">186</biblScope>
			<biblScope unit="page" from="E123" to="142" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">2018-time to act and change the course</title>
		<author>
			<persName><forename type="first">T</forename><surname>Haahtela</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Von Hertzen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Makela</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Hannuksela</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Allergy Programme Working G. Finnish Allergy Programme</title>
		<imprint>
			<biblScope unit="volume">63</biblScope>
			<biblScope unit="page" from="634" to="645" />
			<date type="published" when="2008">2008. 2008</date>
		</imprint>
	</monogr>
	<note>Allergy</note>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Allergy practice worldwide: a report by the World Allergy Organization Specialty and Training Council</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">O</forename><surname>Warner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Kaliner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">D</forename><surname>Crisci</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Del</forename><surname>Giacco</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Frew</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">H</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int Arch Allergy Immunol</title>
		<imprint>
			<biblScope unit="volume">139</biblScope>
			<biblScope unit="page" from="166" to="174" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Early life risk factors for current wheeze, asthma, and bronchial hyperresponsiveness at 10 years of age</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Arshad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Kurukulaaratchy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Fenn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Matthews</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Chest</title>
		<imprint>
			<biblScope unit="volume">127</biblScope>
			<biblScope unit="page" from="502" to="508" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Prebiotic oligosaccharides in dietetic products for infants: a commentary by the ESPGHAN Committee on Nutrition</title>
		<author>
			<persName><forename type="first">C</forename><surname>Agostoni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Axelsson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Goulet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Koletzko</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">F</forename><surname>Michaelsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Puntis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Pediatr Gastroenterol Nutr</title>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="page" from="465" to="473" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">The &quot;Microflora Hypothesis&quot; of allergic disease</title>
		<author>
			<persName><forename type="first">A</forename><surname>Shreiner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">B</forename><surname>Huffnagle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Noverr</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Adv Exp Med Biol</title>
		<imprint>
			<biblScope unit="volume">635</biblScope>
			<biblScope unit="page" from="113" to="134" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">R</forename><surname>Gibson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">B</forename><surname>Roberfroid</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Nutr</title>
		<imprint>
			<biblScope unit="volume">125</biblScope>
			<biblScope unit="page" from="1401" to="1412" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Dietary modulation of the human colonic microbiota: updating the concept of prebiotics</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">R</forename><surname>Gibson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">M</forename><surname>Probert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">V</forename><surname>Loo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Rastall</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">B</forename><surname>Roberfroid</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nutr Res Rev</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="259" to="275" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAID-sponsored expert panel</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Boyce</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Burks</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">W</forename><surname>Jones</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Sampson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">A</forename><surname>Wood</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin Immunol</title>
		<imprint>
			<biblScope unit="volume">126</biblScope>
			<biblScope unit="page" from="S1" to="58" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Computer Program) Version 2.xx</title>
		<author>
			<persName><forename type="first">J</forename><surname>Brożek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Nowak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Kunstman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">J</forename><surname>Schünemann</surname></persName>
		</author>
		<ptr target="http://www.gradepro.org" />
	</analytic>
	<monogr>
		<title level="m">GRADEpro Guideline Development Tool (G2DT)</title>
				<editor>
			<persName><forename type="first">(</forename><surname>Book Gradepro Guideline Development Tool</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">J</forename><surname>G2dt): Brożek</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">A</forename><surname>Nowak</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">P</forename><surname>Kunstman</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">H</forename><forename type="middle">J</forename><surname>Schünemann</surname></persName>
		</editor>
		<imprint>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note>Computer Program) Version 2.xx. Editor ed. ^eds.). City</note>
</biblStruct>

<biblStruct xml:id="b11">
	<monogr>
		<title level="m" type="main">Cochrane Handbook for Systematic Reviews of Interventions Version 5</title>
		<ptr target="http://www.cochrane-handbook.org" />
		<imprint>
			<date type="published" when="2016-02-11">11 Feb 2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">P</forename><surname>Alonso-Coello</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Schunemann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Moberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Brignardello-Petersen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Akl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Davoli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Treweek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Mustafa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Rada</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Rosenbaum</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Morelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">H</forename><surname>Guyatt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>Oxman</surname></persName>
		</author>
		<imprint/>
	</monogr>
	<note>GRADE Evidence to Decision frameworks: 1. Introduction. BMJ. in press</note>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">GRADE Evidence to Decision frameworks: 2. Clinical practice guidelines</title>
		<author>
			<persName><forename type="first">P</forename><surname>Alonso-Coello</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>Oxman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Moberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Brignardello-Petersen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Akl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Davoli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Treweek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Mustafa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Vandvik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Meerpohl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">H</forename><surname>Guyatt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Schunemann</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BMJ</title>
		<imprint/>
	</monogr>
	<note>in press</note>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Development of the GRADE Evidence to Decision (EtD) frameworks for tests in clinical practice and public health</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">J</forename><surname>Schuenemann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Mustafa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Brozek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Santesso</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Alonso-Coello</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Guyatt</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Epidemiol</title>
		<imprint/>
	</monogr>
	<note>in press</note>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Prebiotic supplementation in preterm neonates: Updated systematic review and meta-analysis of randomised controlled trials</title>
		<author>
			<persName><forename type="first">R</forename><surname>Srinivasjois</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Rao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Patole</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Nutr</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="page" from="958" to="965" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Effect of nutrient supplementation on atopic dermatitis in children: A systematic review of probiotics, prebiotics, formula, and fatty acids</title>
		<author>
			<persName><forename type="first">N</forename><surname>Foolad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Brezinski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">P</forename><surname>Chase</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">W</forename><surname>Armstrong</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">JAMA Derm</title>
		<imprint>
			<biblScope unit="volume">149</biblScope>
			<biblScope unit="page" from="350" to="355" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Prebiotics in infants for prevention of allergy</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Osborn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">K</forename><surname>Sinn</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cochrane Database Syst Rev</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page">D006474</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Early dietary intervention with a mixture of prebiotic oligosaccharides reduces the incidence of allergic manifestations and infections during the first two years of life</title>
		<author>
			<persName><forename type="first">S</forename><surname>Arslanoglu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">E</forename><surname>Moro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Schmitt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Tandoi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Rizzardi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Boehm</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Nutr</title>
		<imprint>
			<biblScope unit="volume">138</biblScope>
			<biblScope unit="page" from="1091" to="1095" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Growth and tolerance of infants fed formula supplemented with polydextrose (PDX) and/or galactooligosaccharides (GOS): double-blind, randomized, controlled trial</title>
		<author>
			<persName><forename type="first">C</forename><surname>Ashley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">H</forename><surname>Johnston</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">L</forename><surname>Harris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">I</forename><surname>Stolz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Wampler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">L</forename><surname>Berseth</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nutr J</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="38" to="38" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">A formula containing galacto-and fructo-oligosaccharides prevents intestinal and extra-intestinal infections: an observational study</title>
		<author>
			<persName><forename type="first">E</forename><surname>Bruzzese</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Volpicelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Squeglia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Bruzzese</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Salvini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bisceglia</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Nutr</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="page" from="156" to="161" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Safety and efficacy of inulin and oligofructose supplementation in infant formula: Results from a randomized clinical trial</title>
		<author>
			<persName><forename type="first">R</forename><surname>Closa-Monasterolo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Gispert-Llaurado</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Luque</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Ferre</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Rubio-Torrents</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Zaragoza-Jordana</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Nutr</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="page" from="918" to="927" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">The effect of a prebiotic supplemented formula on growth and stool microbiology of term infants</title>
		<author>
			<persName><forename type="first">C</forename><surname>Costalos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kapiki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Apostolou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Papathoma</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Early Hum Dev</title>
		<imprint>
			<biblScope unit="volume">84</biblScope>
			<biblScope unit="page" from="45" to="49" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Oligofructose-supplemented infant cereal: 2 randomized, blinded, community-based trials in Peruvian infants</title>
		<author>
			<persName><forename type="first">C</forename><surname>Duggan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Penny</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Hibberd</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Gil</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Huapaya</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Cooper</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Clin Nutr</title>
		<imprint>
			<biblScope unit="volume">77</biblScope>
			<biblScope unit="page" from="937" to="942" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Effect of the specific infant formula mixture of oligosaccharides on local immunity and development of allergic and infectious disease in young children: Randomized study</title>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">S</forename><surname>Ivakhnenko</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Nyankovskyy</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pediatr Pol</title>
		<imprint>
			<biblScope unit="volume">88</biblScope>
			<biblScope unit="page" from="398" to="404" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Effects of Hypoallergenic Formula Plus Oligosaccharides on Faecal pH, Growth Pattern and Atopia: A RCT Study in Newborn Infants at Risk for Allergy</title>
		<author>
			<persName><forename type="first">Lista</forename><surname>Gianluca</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Marangione</forename><surname>Paola</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Porcelli</forename><surname>Filippo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Menchini</forename><surname>Massimo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Castoldi</forename><surname>Francesca</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Book Effects of Hypoallergenic Formula Plus Oligosaccharides on Faecal pH, Growth Pattern and Atopia: A RCT Study in Newborn Infants at Risk for Allergy</title>
				<imprint>
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Effects on faecal microbiota of dietary and acidic oligosaccharides in children during partial formula feeding</title>
		<author>
			<persName><forename type="first">F</forename><surname>Magne</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Hachelaf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Suau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Boudraa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Bouziane-Nedjadi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Rigottier-Gois</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Pediatr Gastroenterol Nutr</title>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="page" from="580" to="588" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Effects of fructo-oligosaccharide-supplemented infant cereal: a double-blind, randomized trial</title>
		<author>
			<persName><forename type="first">N</forename><surname>Moore</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Chao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">P</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Storm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Oliva-Hemker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Saavedra</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br J Nutr</title>
		<imprint>
			<biblScope unit="volume">90</biblScope>
			<biblScope unit="page" from="581" to="587" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Effects of early prebiotic and probiotic supplementation on development of gut microbiota and fussing and crying in preterm infants: a randomized, double-blind, placebo-controlled trial</title>
		<author>
			<persName><forename type="first">A</forename><surname>Partty</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Luoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kalliomaki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Salminen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Isolauri</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Pediatr</title>
		<imprint>
			<biblScope unit="volume">163</biblScope>
			<biblScope unit="page" from="1272" to="1277" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Tolerance and safety evaluation in a large cohort of healthy infants fed an innovative prebiotic formula: a randomized controlled trial</title>
		<author>
			<persName><forename type="first">P</forename><surname>Piemontese</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Gianni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">P</forename><surname>Braegger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Chirico</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Gruber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Riedler</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS ONE</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page" from="e28010" to="28010" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">A specific prebiotic mixture added to starting infant formula has long-lasting bifidogenic effects</title>
		<author>
			<persName><forename type="first">F</forename><surname>Salvini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Riva</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Salvatici</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Boehm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Jelinek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Banderali</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Nutr</title>
		<imprint>
			<biblScope unit="volume">141</biblScope>
			<biblScope unit="page" from="1335" to="1339" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Fecal secretory immunoglobulin A is increased in healthy infants who receive a formula with short-chain galacto-oligosaccharides and long-chain fructooligosaccharides</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Scholtens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Alliet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Raes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Alles</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Kroes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Boehm</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Nutr</title>
		<imprint>
			<biblScope unit="volume">138</biblScope>
			<biblScope unit="page" from="1141" to="1147" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Physiological and bifidogenic effects of prebiotic supplements in infant formulae</title>
		<author>
			<persName><forename type="first">G</forename><surname>Veereman-Wauters</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Staelens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Van De Broek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Plaskie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Wesling</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">C</forename><surname>Roger</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Pediatr Gastroenterol Nutr</title>
		<imprint>
			<biblScope unit="volume">52</biblScope>
			<biblScope unit="page" from="763" to="771" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Term infants fed formula supplemented with selected blends of prebiotics grow normally and have soft stools similar to those reported for breast-fed infants</title>
		<author>
			<persName><forename type="first">E</forename><surname>Ziegler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Vanderhoof</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Petschow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Mitmesser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">I</forename><surname>Stolz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">L</forename><surname>Harris</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Pediatr Gastroenterol Nutr</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="page" from="359" to="364" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Reduced occurrence of early atopic dermatitis because of immunoactive prebiotics among low-atopy-risk infants</title>
		<author>
			<persName><forename type="first">C</forename><surname>Gruber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Van Stuijvenberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Mosca</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Moro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Chirico</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">P</forename><surname>Braegger</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin Immunol</title>
		<imprint>
			<biblScope unit="volume">126</biblScope>
			<biblScope unit="page" from="791" to="797" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Dosage-related bifidogenic effects of galacto-and fructooligosaccharides in formula-fed term infants</title>
		<author>
			<persName><forename type="first">G</forename><surname>Moro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Minoli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mosca</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Fanaro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Jelinek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Stahl</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Pediatr Gastroenterol Nutr</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page" from="291" to="295" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">EAACI food allergy and anaphylaxis guidelines. Primary prevention of food allergy</title>
		<author>
			<persName><forename type="first">A</forename><surname>Muraro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Halken</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Arshad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Beyer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">E</forename><surname>Dubois</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Du</forename><surname>Toit</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Allergy</title>
		<imprint>
			<biblScope unit="volume">69</biblScope>
			<biblScope unit="page" from="590" to="601" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Supplementation of infant formula with probiotics and/or prebiotics: a systematic review and comment by the ESPGHAN committee on nutrition</title>
		<author>
			<persName><forename type="first">C</forename><surname>Braegger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Chmielewska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Decsi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kolacek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Mihatsch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Moreno</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Pediatr Gastroenterol Nutr</title>
		<imprint>
			<biblScope unit="volume">52</biblScope>
			<biblScope unit="page" from="238" to="250" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<monogr>
		<title level="m" type="main">Scottish Intercollegiate Guidelines Network (SIGN)</title>
		<ptr target="http://www.sign.ac.uk" />
		<imprint>
			<date type="published" when="2011-02-11">2011. March 2011. 11 Feb 2016</date>
		</imprint>
	</monogr>
	<note>Edinburgh: SIGN</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
